• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机制的SIRT2抑制剂:构效关系、X射线晶体结构、靶点结合、α-微管蛋白乙酰化调控及对乳腺癌细胞迁移的抑制作用

Mechanism-based inhibitors of SIRT2: structure-activity relationship, X-ray structures, target engagement, regulation of α-tubulin acetylation and inhibition of breast cancer cell migration.

作者信息

Nielsen Alexander L, Rajabi Nima, Kudo Norio, Lundø Kathrine, Moreno-Yruela Carlos, Bæk Michael, Fontenas Martin, Lucidi Alessia, Madsen Andreas S, Yoshida Minoru, Olsen Christian A

机构信息

Center for Biopharmaceuticals & Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen Universitetsparken 2 DK-2100 Copenhagen Denmark

RIKEN Center for Sustainable Resource Science (S13) Hirosawa 2-1 Wako Saitama 351-0198 Japan.

出版信息

RSC Chem Biol. 2021 Jan 14;2(2):612-626. doi: 10.1039/d0cb00036a. eCollection 2021 Apr 1.

DOI:10.1039/d0cb00036a
PMID:34458803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8341974/
Abstract

Sirtuin 2 (SIRT2) is a protein deacylase enzyme that removes acetyl groups and longer chain acyl groups from post-translationally modified lysine residues. It affects diverse biological functions in the cell and has been considered a drug target in relation to both neurodegenerative diseases and cancer. Therefore, access to well-characterized and robust tool compounds is essential for the continued investigation of the complex functions of this enzyme. Here, we report a collection of chemical probes that are potent, selective, stable in serum, water-soluble, and inhibit SIRT2-mediated deacetylation and demyristoylation in cells. Compared to the current landscape of SIRT2 inhibitors, this is a unique ensemble of features built into a single compound. We expect the developed chemotypes to find broad application in the interrogation of SIRT2 functions in both healthy and diseased cells, and to provide a foundation for the development of future therapeutics.

摘要

沉默调节蛋白2(SIRT2)是一种蛋白质脱酰基酶,可从翻译后修饰的赖氨酸残基上去除乙酰基和长链酰基。它影响细胞中的多种生物学功能,并且在神经退行性疾病和癌症方面均被视为药物靶点。因此,获得特征明确且稳定的工具化合物对于持续研究该酶的复杂功能至关重要。在此,我们报告了一系列化学探针,这些探针具有强效、选择性、在血清中稳定、水溶性好的特点,并且能够抑制细胞中SIRT2介导的去乙酰化和去肉豆蔻酰化。与目前的SIRT2抑制剂情况相比,这是单个化合物中所具备的独特特征组合。我们期望所开发的化学类型能够在研究健康细胞和患病细胞中SIRT2功能方面得到广泛应用,并为未来治疗药物的开发提供基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b1f0438baef0/d0cb00036a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b0b06bc5feb9/d0cb00036a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/0a6c0bf6a162/d0cb00036a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b2af342f0c41/d0cb00036a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/fee91b843303/d0cb00036a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/a88fc3d22fd7/d0cb00036a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/5b3ebcd2f5d9/d0cb00036a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/2f38842bb9dd/d0cb00036a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b1f0438baef0/d0cb00036a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b0b06bc5feb9/d0cb00036a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/0a6c0bf6a162/d0cb00036a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b2af342f0c41/d0cb00036a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/fee91b843303/d0cb00036a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/a88fc3d22fd7/d0cb00036a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/5b3ebcd2f5d9/d0cb00036a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/2f38842bb9dd/d0cb00036a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53e0/8341974/b1f0438baef0/d0cb00036a-f7.jpg

相似文献

1
Mechanism-based inhibitors of SIRT2: structure-activity relationship, X-ray structures, target engagement, regulation of α-tubulin acetylation and inhibition of breast cancer cell migration.基于机制的SIRT2抑制剂:构效关系、X射线晶体结构、靶点结合、α-微管蛋白乙酰化调控及对乳腺癌细胞迁移的抑制作用
RSC Chem Biol. 2021 Jan 14;2(2):612-626. doi: 10.1039/d0cb00036a. eCollection 2021 Apr 1.
2
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.X 射线晶体结构指导发现新型选择性、底物模拟的 SIRT2 抑制剂,对非小细胞肺癌细胞具有活性。
Eur J Med Chem. 2018 Jul 15;155:806-823. doi: 10.1016/j.ejmech.2018.06.041. Epub 2018 Jun 19.
3
Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.开发一种纳米生物发光共振能量转移(NanoBRET)检测方法,以验证抑制Sirt2介导的赖氨酸去乙酰化和去脂肪酰化从而阻断前列腺癌细胞迁移的抑制剂。
RSC Chem Biol. 2022 Mar 1;3(4):468-485. doi: 10.1039/d1cb00244a. eCollection 2022 Apr 6.
4
Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.具有抗增殖特性的色满酮-4-酮和色酮类 SIRT2 抑制剂在癌细胞中的应用。
J Med Chem. 2014 Dec 11;57(23):9870-88. doi: 10.1021/jm500930h. Epub 2014 Dec 2.
5
Emerging role of SIRT2 in non-small cell lung cancer.SIRT2在非小细胞肺癌中的新作用。
Oncol Lett. 2021 Oct;22(4):731. doi: 10.3892/ol.2021.12992. Epub 2021 Aug 11.
6
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.发现 2-((4,6-二甲基嘧啶-2-基)硫代)-N-苯基乙酰胺衍生物作为新型强效和选择性的人 SIRT2 抑制剂。
Eur J Med Chem. 2017 Jul 7;134:230-241. doi: 10.1016/j.ejmech.2017.04.010. Epub 2017 Apr 12.
7
Discovery of Selective SIRT2 Inhibitors as Therapeutic Agents in B-Cell Lymphoma and Other Malignancies.发现选择性 SIRT2 抑制剂作为 B 细胞淋巴瘤和其他恶性肿瘤的治疗药物。
Molecules. 2020 Jan 21;25(3):455. doi: 10.3390/molecules25030455.
8
Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.新型人源 SIRT2 选择性抑制剂的设计、合成及生物活性研究。
J Med Chem. 2012 Jun 28;55(12):5760-73. doi: 10.1021/jm3002108. Epub 2012 Jun 12.
9
Effects of Dimerization on the Deacylase Activities of Human SIRT2.二聚化对人源 SIRT2 的去酰基酶活性的影响。
Biochemistry. 2023 Dec 5;62(23):3383-3395. doi: 10.1021/acs.biochem.3c00381. Epub 2023 Nov 15.
10
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.利用共识对接/评分策略和构效关系分析发现新型 SIRT2 抑制剂。
J Chem Inf Model. 2017 Apr 24;57(4):669-679. doi: 10.1021/acs.jcim.6b00714. Epub 2017 Mar 28.

引用本文的文献

1
Sirtuins in Central Nervous System Tumors-Molecular Mechanisms and Therapeutic Targeting.中枢神经系统肿瘤中的沉默调节蛋白——分子机制与治疗靶点
Cells. 2025 Jul 19;14(14):1113. doi: 10.3390/cells14141113.
2
Structural basis for sirtuin 2 activity and modulation: Current state and opportunities.沉默调节蛋白2的活性与调控的结构基础:现状与机遇
J Biol Chem. 2025 May 22;301(7):110274. doi: 10.1016/j.jbc.2025.110274.
3
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand Interactions.无辅基Sirt2的高效结晶用于小分子浸泡及配体相互作用的结构分析

本文引用的文献

1
Dethioacylation by Sirtuins 1-3: Considerations for Drug Design Using Mechanism-Based Sirtuin Inhibition.沉默调节蛋白1-3介导的去硫酰化作用:基于机制的沉默调节蛋白抑制用于药物设计的考量
ACS Med Chem Lett. 2020 Feb 6;11(10):1886-1892. doi: 10.1021/acsmedchemlett.9b00580. eCollection 2020 Oct 8.
2
Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.Sirt2 抑制增强了肿瘤反应性 T 细胞的代谢适应性和效应功能。
Cell Metab. 2020 Sep 1;32(3):420-436.e12. doi: 10.1016/j.cmet.2020.07.008. Epub 2020 Aug 7.
3
An amber obligate active site-directed ligand evolution technique for phage display.
J Med Chem. 2025 Jun 12;68(11):10771-10780. doi: 10.1021/acs.jmedchem.4c02896. Epub 2025 May 20.
4
Discovery of De Novo Macrocycle Inhibitors of Histone Deacetylase 11.组蛋白去乙酰化酶11的新型大环抑制剂的发现。
JACS Au. 2025 Feb 16;5(3):1299-1307. doi: 10.1021/jacsau.4c01148. eCollection 2025 Mar 24.
5
Structural basis of SIRT7 nucleosome engagement and substrate specificity.SIRT7与核小体结合及底物特异性的结构基础。
Nat Commun. 2025 Feb 4;16(1):1328. doi: 10.1038/s41467-025-56529-y.
6
SIRT2 Inhibition by AGK2 Promotes Perinuclear Cytoskeletal Organisation and Reduces Invasiveness of MDA-MB-231 Triple-Negative Breast Cancer Cells in Confined In Vitro Models.AGK2抑制SIRT2可促进核周细胞骨架组织形成,并降低MDA-MB-231三阴性乳腺癌细胞在体外受限模型中的侵袭能力。
Cells. 2024 Dec 7;13(23):2023. doi: 10.3390/cells13232023.
7
Drugs Targeting Sirtuin 2 Exhibit Broad-Spectrum Anti-Infective Activity.靶向沉默调节蛋白2的药物具有广谱抗感染活性。
Pharmaceuticals (Basel). 2024 Sep 29;17(10):1298. doi: 10.3390/ph17101298.
8
Symmetrical 2,7-disubstituted 9H-fluoren-9-one as a novel and promising scaffold for selective targeting of SIRT2.对称的2,7-二取代9H-芴-9-酮作为一种新型且有前景的选择性靶向SIRT2的骨架。
Arch Pharm (Weinheim). 2024 Dec;357(12):e2400661. doi: 10.1002/ardp.202400661. Epub 2024 Sep 28.
9
Thioamides in medicinal chemistry and as small molecule therapeutic agents.硫代酰胺在药物化学中以及作为小分子治疗剂。
Eur J Med Chem. 2024 Nov 5;277:116732. doi: 10.1016/j.ejmech.2024.116732. Epub 2024 Aug 5.
10
A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors.一种均相时间分辨荧光屏,用于鉴定 SIRT2 脱乙酰酶和脱脂酶抑制剂。
PLoS One. 2024 Jun 24;19(6):e0305000. doi: 10.1371/journal.pone.0305000. eCollection 2024.
噬菌体展示的琥珀型必需活性位点定向配体进化技术。
Nat Commun. 2020 Mar 13;11(1):1392. doi: 10.1038/s41467-020-15057-7.
4
SIRT2 and Lysine Fatty Acylation Regulate the Activity of RalB and Cell Migration.SIRT2 和赖氨酸脂肪酸化调节 RalB 的活性和细胞迁移。
ACS Chem Biol. 2019 Sep 20;14(9):2014-2023. doi: 10.1021/acschembio.9b00492. Epub 2019 Sep 3.
5
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.已知小分子 Keap1-Nrf2 蛋白-蛋白相互作用抑制剂的比较评估研究:化学合成、结合特性和细胞活性。
J Med Chem. 2019 Sep 12;62(17):8028-8052. doi: 10.1021/acs.jmedchem.9b00723. Epub 2019 Aug 27.
6
A Glycoconjugated SIRT2 Inhibitor with Aqueous Solubility Allows Structure-Based Design of SIRT2 Inhibitors.一种具有水溶性的糖缀合 SIRT2 抑制剂,可实现基于结构的 SIRT2 抑制剂设计。
ACS Chem Biol. 2019 Aug 16;14(8):1802-1810. doi: 10.1021/acschembio.9b00384. Epub 2019 Aug 2.
7
Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD-Binding Site.鉴定含二酮哌嗪的 2-苯胺甲酰胺作为靶向“选择性口袋”、底物结合位点和 NAD 结合位点的强效 Sirtuin 2(SIRT2)选择性抑制剂。
J Med Chem. 2019 Jun 27;62(12):5844-5862. doi: 10.1021/acs.jmedchem.9b00255. Epub 2019 Jun 12.
8
Development of Peptide-Based Sirtuin Defatty-Acylase Inhibitors Identified by the Fluorescence Probe, SFP3, That Can Efficiently Measure Defatty-Acylase Activity of Sirtuin.基于荧光探针 SFP3 的 Sirtuin 脱酰酶抑制剂的开发,该探针可高效测量 Sirtuin 的脱酰酶活性。
J Med Chem. 2019 Jun 13;62(11):5434-5452. doi: 10.1021/acs.jmedchem.9b00315. Epub 2019 May 30.
9
Evaluation of thioamides, thiolactams and thioureas as hydrogen sulfide (HS) donors for lowering blood pressure.评估硫酰胺、硫内酰胺和硫脲作为降低血压的硫化氢 (HS) 供体。
Bioorg Chem. 2019 Jul;88:102941. doi: 10.1016/j.bioorg.2019.102941. Epub 2019 Apr 22.
10
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.新型赖氨酸基硫脲类化合物作为 Sirtuin 2(SIRT2)的基于机制的抑制剂,在结直肠癌小鼠模型中具有抗癌活性。
J Med Chem. 2019 Apr 25;62(8):4131-4141. doi: 10.1021/acs.jmedchem.9b00191. Epub 2019 Apr 15.